Monocyte Differentiation Up-regulates the Expression of the Lysosomal Sialidase, Neu1, and Triggers Its Targeting to the Plasma Membrane via Major Histocompatibility Complex Class II-positive Compartments*

Human sialidase (neuraminidase) Neu1 catalyzes lysosomal catabolism of sialylated glycoconjugates. Here we show that during the differentiation of monocytes and the monocytic cell line, THP-1, into macrophages, the majority of Neu1 relocalizes from the lysosomes to the cell surface. In contrast to other cellular sialidases Neu2, Neu3, and Neu4, whose expression either remains unchanged or is down-regulated, Neu1 mRNA, protein and activity are specifically increased during the phorbol 12-myristate 13-acetate-induced differentiation, consistent with a significant induction of the transcriptional activity of the Neu1 gene promoter. The lysosomal carboxypeptidase, cathepsin A, which forms a complex with and activates Neu1 in the lysosome, is sorted to the plasma membrane of the differentiating cells similarly to Neu1. Both proteins are first targeted to the lysosome and then are sorted to the LAMP-2-negative, major histo-compatibility complex II-positive vesicles, which later merge with the plasma membrane. Similar trafficking was observed for the internalized fluorescent dextran or horseradish peroxidase initially stored in the lysosomal/endosomal compartment. The suppression of Neu1 expression in the THP-1-derived macrophages by small interfering RNA or with anti-Neu1 antibodies significantly reduced the ability of the cells to engulf bacteria or to produce cytokines. Altogether our data suggest that the upregulation of the Neu1 expression is important for the primary function of macrophages and establish the link between Neu1 and the cellular immune response.

[1]  A. Pshezhetsky,et al.  Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages , 2005, The FEBS journal.

[2]  J. Auwerx,et al.  The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation , 1991, Experientia.

[3]  A. Pshezhetsky,et al.  Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells* , 2004, Journal of Biological Chemistry.

[4]  M. Billah,et al.  Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. , 2004, The Biochemical journal.

[5]  H. Ploegh,et al.  Class II MHC peptide loading by the professionals. , 2004, Current opinion in immunology.

[6]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[7]  T. Aoyagi,et al.  Differential effect of various inhibitors on four types of rat sialidase , 1993, Glycoconjugate Journal.

[8]  R. Cook,et al.  Activation of T lymphocytes results in an increase inH-2-encoded neuraminidase , 2004, Immunogenetics.

[9]  A. Pshezhetsky,et al.  Molecular pathology of NEU1 gene in sialidosis , 2003, Human mutation.

[10]  Ashok Kumar,et al.  Tumor Necrosis Factor-α Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells* , 2003, Journal of Biological Chemistry.

[11]  P. Crocker,et al.  Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. , 2002, Current opinion in structural biology.

[12]  K. Lukong,et al.  Intracellular Distribution of Lysosomal Sialidase Is Controlled by the Internalization Signal in Its Cytoplasmic Tail* , 2001, The Journal of Biological Chemistry.

[13]  T. Miyagi,et al.  Degradation of G(M1) and G(M2) by mammalian sialidases. , 2001, The Biochemical journal.

[14]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[15]  A. Pshezhetsky,et al.  Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology. , 2001, Progress in nucleic acid research and molecular biology.

[16]  Xin Chen,et al.  The TRANSFAC system on gene expression regulation , 2001, Nucleic Acids Res..

[17]  X. Ding,et al.  Ganglioside control over IL-4 priming and cytokine production in activated T cells. , 2000, Cytokine.

[18]  R. Steinman,et al.  Transport of peptide-MHC class II complexes in developing dendritic cells. , 2000, Science.

[19]  G. Borsani,et al.  Expression of a novel human sialidase encoded by the NEU2 gene. , 1999, Glycobiology.

[20]  A. Tominaga,et al.  Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. , 1999, Journal of immunology.

[21]  K. Lukong,et al.  Identification of UDP-N-acetylglucosamine-phosphotransferase-binding sites on the lysosomal proteases, cathepsins A, B, and D. , 1999, Biochemistry.

[22]  K. Lukong,et al.  Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. , 1998, The Biochemical journal.

[23]  R. Rottier,et al.  A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse. , 1998, Human molecular genetics.

[24]  R. Daynes,et al.  The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase. , 1997, Journal of immunology.

[25]  H. Kamata,et al.  Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. , 1997, Biochemical and biophysical research communications.

[26]  Daniel Leclerc,et al.  Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis , 1997, Nature Genetics.

[27]  R. Campbell,et al.  Identification of a Sialidase Encoded in the Human Major Histocompatibility Complex* , 1997, The Journal of Biological Chemistry.

[28]  M. Fornerod,et al.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. , 1996, Genes & development.

[29]  P. Cresswell,et al.  HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. , 1996, Immunity.

[30]  N. Galjart,et al.  Lysosomal Protective Protein/Cathepsin A , 1995, The Journal of Biological Chemistry.

[31]  T. Cruz,et al.  Involvement of Reactive Oxygen Species in Cytokine and Growth Factor Induction of c-fos Expression in Chondrocytes(*) , 1995, The Journal of Biological Chemistry.

[32]  P. Cresswell,et al.  Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles , 1995, The Journal of experimental medicine.

[33]  R. Kumashiro,et al.  Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. , 1993, Journal of immunology.

[34]  A. Takeshita,et al.  Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.

[35]  A. Varki,et al.  Preparation and Analysis of Glycoconjugates , 1993 .

[36]  M. Klüppel,et al.  Reporter constructs with low background activity utilizing the cat gene. , 1992, Gene.

[37]  N. Galjart,et al.  Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. , 1991, The Journal of biological chemistry.

[38]  G. Ringold,et al.  TNF induces c‐fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. , 1991, The EMBO journal.

[39]  M. Cantz,et al.  Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors. , 1991, Biological chemistry Hoppe-Seyler.

[40]  J. Cook,et al.  Reporter genes: application to the study of mammalian gene transcription. , 1990, Analytical biochemistry.

[41]  M. Potier,et al.  Deficient lysosomal carboxypeptidase activity in galactosialidosis. , 1990, Biochemical and biophysical research communications.

[42]  I. Verma,et al.  Nuclear proto-oncogenes fos and jun. , 1990, Annual review of cell biology.

[43]  B. Franza,et al.  The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. , 1989, Genes & development.

[44]  N. Galjart,et al.  Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta. , 1989, The Journal of biological chemistry.

[45]  B. Franza,et al.  Fos and jun: The AP-1 connection , 1988, Cell.

[46]  A. Schönthal,et al.  Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters , 1988, Cell.

[47]  R. Tjian,et al.  Fos-associated protein p39 is the product of the jun proto-oncogene. , 1988, Science.

[48]  B. Spiegelman,et al.  Common DNA binding site for Fos protein complexesand transcription factor AP-1 , 1988, Cell.

[49]  V. Muronetz,et al.  Association of glyceraldehyde-3-phosphate dehydrogenase with mono- and polyribosomes of rabbit reticulocytes. , 1988, European journal of biochemistry.

[50]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[51]  R. Cook,et al.  Activated T-lymphocytes express class I molecules which are hyposialylated compared to other lymphocyte populations. , 1986, Molecular immunology.

[52]  K. Tada,et al.  Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. , 1982, Cancer research.

[53]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[54]  L. Rome,et al.  Two species of lysosomal organelles in cultured human fibroblasts , 1979, Cell.

[55]  M. Potier,et al.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. , 1979, Analytical biochemistry.

[56]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[57]  E. Schmidt Glutamate Dehydrogenase UV-Assay , 1974 .

[58]  B. Goldin,et al.  L-Glutamate Dehydrogenases* , 1971 .

[59]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .